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Abstract
Background: Ectopic Wnt signaling induces increased stem/progenitor cell activity in the mouse mammary gland, followed
by tumor development. The Wnt signaling receptors, Lrp5/6, are uniquely required for canonical Wnt activity. Previous data
has shown that the absence of Lrp5 confers resistance to Wnt1-induced tumor development.
Methodology/Principal Findings: Here, we show that all basal mammary cells express Lrp5, and co-express Lrp6 in a similar
fashion. Though Wnt dependent transcription of key target genes is relatively unchanged in mammary epithelial cell
cultures, the absence of Lrp5 specifically depletes adult regenerative stem cell activity (to less than 1%). Stem cell activity
can be enriched by .200 fold (over 80% of activity), based on high Lrp5 expression alone. Though Lrp5 null glands have
apparent normal function, the basal lineage is relatively reduced (from 42% basal/total epithelial cells to 22%) and Lrp52/2
mammary epithelial cells show enhanced expression of senescence-associated markers in vitro, as measured by expression
of p16
Ink4a and TA-p63.
Conclusions/Significance: This is the first single biomarker that has been demonstrated to be functionally involved in stem
cell maintenance. Together, these results demonstrate that Wnt signaling through Lrp5 is an important component of
normal mammary stem cell function.
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Introduction
The Wnt signaling pathway is required for normal development,
but when ectopically expressed, is highly oncogenic for human
epithelia [1]. Wnt signaling is used at many different developmental
stages, as an effector of pathways involved in processes as distinct as
planar cell polarity, neuronal axon guidance and the activation and
regulation of somatic epithelial stem/progenitor cell compartments
[2,3,4,5]. This latter function appears to be key to the oncogenic
role of Wnt signaling. In gut, the mutation of key tumor suppressor
molecules in the Wnt signaling pathway leads to amplification of
stem/progenitor compartments, followed by the appearance of
differentiated adenomas and tumors [6,7,8]. Our previous data has
shown that gain of function of Wnt signaling in mammary glands
also induces an increase in the stem/progenitor cell activity in the
preneoplastic condition [9].
In order to understand the normal function of Wnt signaling in
mammary glands, we chose to study how loss of function of Wnt
signaling affected mammary development.
There are many Wnt-dependent signaling events, but only one
pathway has so far been associated with the stem cell functions and
oncogenic properties. This so-called canonical pathway is
mediated by the interaction of Wnt ligands with a pair of cell
surface receptors, comprising a Frizzled receptor and an Lrp5 or -
6 receptor [10,11]. Binding of the Wnt ligand to the Frizzled and
Lrp5/6 receptor is followed by the recruitment of axin from the b-
catenin destruction complex, stabilization of b-catenin and,
transactivation of specific target genes via a b-catenin/TCF
complex [12].
There are many members of the Wnt family of secreted
lipoglycoprotein ligands [13], and several (Wnt-2,-4,-5a,-5b,6,7b)
are expressed during mammary gland development
[14,15,16,17,18]. Similarly, there are 10 known Frizzled homo-
logues, of which Frizzled 1–8 are known to be expressed in
mammary epithelial cells [19]. However, there is an absolute
requirement for either Lrp5 or Lrp6 for canonical Wnt signaling
[20]. Lrp5 and -6 belong to the LDL receptor related protein
family of single-span transmembrane receptors, which mediate
binding and internalization of various lipoprotein particles [21].
Current studies have not addressed whether Lrp5 and Lrp6
have distinct molecular properties. Ablation of Lrp5 and Lrp6
produce entirely different phenotypes in mice. Lrp6 expression
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6594appears to be widespread in embryonic tissues and is essential for
embryonic development. Mammary development fails in the
absence of Lrp6; both epithelial outgrowth of the placode and the
formation of the host adipose tissue is affected [22]. The role of
Lrp6 in adult tissues is unclear, but loss of function mutations have
been linked with human cases of coronary artery disease [23]. In
contrast, Lrp5 null mice are viable, although they exhibit defects in
bone ossification and vascularization of the eye [24,25]. In adult
tissues, Lrp5 mRNA and protein levels are high and widely
expressed in tissues such as bone, pancreas, central nervous
system, and in phagocytic cells [21,26]. Loss of function mutations
have been associated with heritable cases of osteoporosis as well as
Type I diabetes [27,28].
In the mammary gland, Wnt signaling is required for
specification and outgrowth of the mammary rudiment from the
embryonic skin [16], and a Wnt reporter strain shows high Wnt
signaling activity at this stage [15,29]. Since inhibition of Wnt
signaling prevents gland formation [15], it has been difficult to
determine the functional role of Wnt signaling in later and adult
stages of mammary gland development.
Wnt signaling has been shown to be important not only to the
maintenance of stem/progenitor compartments in gut, but in a
number of other cell lineages. These include hematopoetic and
embryonic stem cells [30,31,32]. Specifically, several compo-
nents of the canonical Wnt signaling pathway have been found
to be expressed in both embryonic and hematopoetic stem cell
populations. Moreover, treatment with Wnt ligands or down-
stream activation of the Wnt signaling pathway inhibits
differentiation and promotes self-renewal of these cells [30,31].
Studies published in 2006 [33,34] showed that subpopulations
of basal mammary cells could be isolated from the total
population, that show enhanced regenerative capacity when
assayed in vivo (described by their ability to regenerate a
mammary tree when transferred to a host cleared fat pad). A
single cell from this population was sufficient to recreate a whole
gland, and they were coined somatic mammary stem cells.
These subpopulations are separated by their high expression of
both CD24 and CD49f (a6 integrin, or CD29, b1 integrin), but
their purity is unlikely to be higher than 5%. Neither of these
markers alone is useful for the identification of stem cells, or
indeed resolution of whole mammary epithelial cell populations.
Therefore, the behavior of the cells that are key to the growth or
regeneration of glands has not yet been described. It has become
a high priority to find a molecule (preferably one functionally
involved in determining stemness) that is a specific marker of
stem cell function, for their evaluation during normal and
pathogenic development.
Previously, we showed that Lrp5 null mammary glands, though
grossly normal (albeit developmentally delayed), were remarkably
resistant to Wnt1-induced tumor development [29]. This resis-
tance occurred despite the presence of Lrp6, and served to focus
our attention on the specific functions of Lrp5. Lrp5 null glands
were almost devoid of regenerative potential when tested by in vivo
stem cell assay. Here, we show that both Lrp5 and -6 proteins are
expressed in the basal epithelial cell population. We also show that
the loss of Lrp5 does not significantly affect the response of cultured
mammary epithelial cells (MECs), tested with an in vitro Wnt
reporter assay. The absence of Lrp5 generates a selective loss of the
basal cell population, though the function of mammary glands is
entirely preserved. Furthermore, the cells tend to become
senescent in culture. In addition, we find that cells expressing
high levels of Lrp5 co-localize with the CD24/CD49f double-
positive stem cell-enriched fraction and have enhanced stem cell
function in vivo.
Results
Lrp5 and 6 Expression is Localized to Basal Mammary
Epithelial Cells
Lrp5 and Lrp6 proteins contain .70% amino acid sequence
homology [21]. Prior studies have shown no clear patterns of
expression of Lrp5 and -6, depending upon the antibody reagents
used, the assay, and the fixation conditions. To ensure that our
analyses can resolve Lrp5 and Lrp6, we transfected HEK293 cells
with constructs coding for either Lrp5 or Lrp6. Western blotting,
immunofluorescence, and flow cytometry staining of transfected
293 cells found both Lrp5 and Lrp6 antibodies were specific to
each receptor (Figure S1).
By immunofluorescent assay, quiescent virgin glands showed
specific staining of Lrp5 in basal epithelial cells (determined by
their co-expression of either keratin 5 (K5) or smooth muscle actin
(SMA); Fig. 1), but not luminal cells. Interestingly, we did observe
specific staining in the stroma of Lrp5 +/+ mammary glands,
which was absent in Lrp5 2/2 glands. There was high
background staining of the adipocytes in these paraffin-embedded
samples, demonstrated by a persistent staining pattern in these
cells in Lrp52/2 glands, where the specific basal cell-associated
stain is absent. Overall, ductal development and morphogenesis in
Lrp52/2 mammary glands is almost normal (a little delayed and
hypo-branched; Lindvall et al 2006). These immunohistochemical
data show that the relative cellular architecture and arrangement
is also normal.
In frozen sections of mammary glands from pregnant mice, we
confirmed that the morphogenesis and growth typical of this stage
is normal, and that the basal cell pattern of expression was
continued (co-localization with basal markers, and exclusion from
luminal, keratin 8 (K8)-positive cells).
Northern analysis of mRNA and Western analysis of proteins
from embryos and isolated MECs confirmed the loss of Lrp5
expression in these mice (Fig. 1B). Lrp5 mRNA was expressed at
similar levels in glands from both virgin and pregnant mice. In the
absence of Lrp5, there was no significant compensatory upregula-
tion of Lrp6 (at the mRNA level)
To verify that Lrp5 was expressed in basal cells, we used the
flow cytometric analysis of BALB/c MECs described by Stingl et
al, separating basal and luminal cells by their dual staining with
CD24 and CD49f [34]. Analysis of Lrp5 expression in addition to
CD24 and CD49f revealed that Lrp5 expression was predomi-
nantly localized to the basal lineage (Fig. 2A). Though the intensity
of Lrp5 staining was much lower in C57Bl6 MECs, analysis of this
strain also showed that only basal cells expressed Lrp5, and that
this staining was absent in the corresponding C57Bl6 Lrp5 2/2
MECs (Figure S2).
The expression of Lrp5 was not equal in all basal cells; indeed
the non-regenerative myoepithelial population (relatively lower
CD24/CD49f; Stingl et al 2006) had low Lrp5 expression,
whereas the regenerative mammary repopulating units (MRU)
fraction had higher Lrp5 expression levels (Fig. 2A and B).
Isolation of cell fractions by flow cytometry, followed by staining of
sorted populations with antibodies to keratin 5 (K5) and -8 (K8)
confirmed that the accuracy of gating for the basal and luminal cell
populations was high. Likewise, isolation and staining of the Lrp5-
positive and -negative populations for K5 and K8 showed that the
Lrp5-positive population consists predominantly of basal cells and
the Lrp5 negative population contains mostly luminal cells
(Fig. 2C).
Staining of BALB/c MECs with anti-Lrp6, in addition to CD24
and CD49f, demonstrated that Lrp6 is also predominantly
localized to the basal cell lineage (Fig. 3A) and the magnitude of
Lrp5 in Mammary Stem Cells
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6594Figure 1. Lrp5 is Expressed in Mouse Mammary Epithelial Cells. A) Western blot of lysates prepared from E10-12 Lrp5 +/+ and 2/2 embryos,
primary MECs, and the NMuMG and HC11 cell lines. B) Northern blots of RNA prepared from E18 Lrp5 +/+, +/2, 2/2 embryos, primary virgin (V) and
14 day pregnant (P) MECs, NMuMG and HC11 cell lines were probed for either Lrp5 or Lrp6 mRNA expression. 18S was used as a loading control. C)
Immunohistochemistry was used to localize Lrp5-expressing cells in virgin Lrp5 +/+ and 2/2 paraffin embedded mammary glands. Lrp5 (green) was
co-localized with K5 or SMA (red), and nuclei stained with ToPro3 (blue) as indicated, scale bars=20 mm. Insets depict 56enlargements, scale
bars=4 mm. D) Frozen sections of 10 day pregnant mammary glands from Lrp5 +/+ and 2/2 mice were subjected to the same analysis, scale
bars=20 mm.
doi:10.1371/journal.pone.0006594.g001
Lrp5 in Mammary Stem Cells
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6594Lrp6 expression is greater in basal cells expressing high levels of
CD49f and CD24 (Fig. 3B). Furthermore, staining of isolated Lrp6
positive cells for K5 and K8 showed that these cells are
predominantly basal (Fig. 3C). We conclude that most basal cells
express both Lrp5 and Lrp6.
High Lrp5 Expression Identifies a Stem Cell Enriched
Population
Previously, CD24
+CD49f
high antibody staining has been shown
to identify a population of MECs highly enriched in stem cell
activity, termed mammary repopulating units (MRU) [33,34]. The
stem cell frequency of the MRU fraction was estimated to be 1/
60–1/90 cells based on ductal outgrowth upon transplantation
into cleared fat pads [34,35]. To evaluate the functional stem cell
activity of Lrp5-expressing cells, we separated high- and low Lrp5-
expressing cells. Flow cytometric analysis using differential C49f/
CD24 staining pattern showed that the Lrp5-high cells were
enriched in the MRU fraction (Fig. 4A). Approximately 50% of
Lrp5-high cells were distributed to a previously undefined region
of the CD24/CD49f FACS profile. Further analysis revealed this
fraction primarily contained von Willebrand factor (VWB) positive
endothelial cells (Fig. 4B). Although CD31 positive cells were
excluded by previous gating, sorting and staining of Lrp5 negative
and positive populations, confirmed that approximately 40% of
the Lrp5-positive cell fraction was VWB positive (Fig. 4C).
Transplantation of Lrp5 high cells in limiting dilutions into
cleared fat pads demonstrated that Lrp5 high cells possess
significantly augmented ductal stem cell activity compared to the
whole population (Fig. 5A). The estimated stem cell frequency was
found to increase from 1/7,760 cells in the whole population to 1/
485 in the Lrp5-high fraction (a 16-fold enrichment in mammary
stem cells; Fig. 5B). In addition, Lrp5 negative cells were depleted
of ductal stem cell activity (1/107,272 cells) compared to the whole
population, and the overall recovery of stem cell function in the
Lrp5-high fraction was 80%. Based on this one marker (and
assuming a 50% dilution with VWB-positive endothelial cells), the
overall stem cell enrichment is only 3-fold lower than in the MRU
fractionation protocol (p=0.049, Fig. 5B).
Using limiting cell dilutions (10k C57Bl6 MECs) and scoring
both the robust outgrowths and partial outgrowths, we confirmed
that Lrp5-/cells have less stem cell activity. Interestingly,
outgrowths from mixtures of control and Lrp52/2 cells contained
labeled (control) and unlabeled Lrp52/2 cells. In other words,
outgrowths were not clonal and Lrp52/2 cells can contribute to
outgrowths in the presence of wild type cells (Figure S3).
Although stem cell populations are clearly depleted in Lrp52/2
glands, this has no obvious effect on function of glands during
pregnancy; indeed there are no differences in lactation of
multiparous Lrp52/2 breeders, or in their mammary ductal trees
(Figure S4), despite at least 8 months of estrus cycling and 3
pregnancies. We conclude that regenerative basal stem cells are not
required to contribute to lobuloalveolar development.
Lrp5 Expression is Required for Maintenance of the Basal
Cell Layer
Since Lrp5 positive cells are localized to the basal epithelial
layer and ductal stem cell activity is depleted in Lrp5 null
mammary glands, we quantified basal cells in populations of
Figure 2. Lrp5 is Expressed by Basal Mammary Epithelial Cells. A) BALB/c virgin MECs were stained with CD24, CD49f, and Lrp5 prior to FACS
analysis. MECs were gated for positive (blue) and negative (red) Lrp5 expression and the subsequent CD24/CD49f profile of the populations were
overlaid. B) Basal MECs were gated based on the magnitude of CD24/CD49f expression level, as CD24
low/CD49f
low (1, red) or CD24
high/CD49f
high
(2, black). The relative Lrp5 expression levels of each population were then overlaid as histograms. C) Basal, Luminal, Lrp5+, Lrp5-, and whole
population (WP) MEC fractions (gates show in A) were isolated by FACS and subsequently stained for K5 and K8 to confirm their purity and cellular
phenotype.
doi:10.1371/journal.pone.0006594.g002
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difficult to quantify basal cell depletion in vivo (Fig. 1), flow
cytometric analysis revealed a two-fold depletion of basal cells with
respect to total epithelial cells (Fig. 6A). The frequency of basal
cells in the total mammary epithelial cell population decreased
from approximately 4.2 to 2.2 basal cells per 10 epithelial cells. In
contrast, basal cell frequency increased in C57Bl6 MMTV-Wnt1
(MMTV-Wnt1) hyperplastic MECs, suggesting that Lrp5-depen-
dent Wnt signaling is important for normal differentiation of basal
cells.
To confirm this result, we assessed the level of expression of
lineage-specific markers using biochemical analysis. Lysates were
prepared from primary MECs isolated from Lrp5 +/+, Lrp5 2/2,
and MMTV-Wnt1 mice (to examine the loss- and gain of function
conditions). There was less (0.36) K5 expressed in Lrp52/2
glands, and slightly more (1.2) in glands from MMTV-Wnt1 mice
(Fig. 6B). A similar pattern was observed for K5 mRNA expression
in isolated Lrp5 2/2 and MMTV-Wnt1 MECs as well as from
E10-12 embryos (Figure S5). Microarray analysis of Lrp5 +/+ and
2/2 MECs further corroborated the relative depletion of cells
with the basal phenotype in Lrp5 2/2 MECs, where the basal
markers K5 and p63 were found to be significantly down-
regulated 0.57- and 0.68-fold, respectively, compared to Lrp5+/+
MECs (Fig. 6C). In addition, analysis of markers previously
characterized to define the MRU sub-population were found to be
relatively down-regulated in Lrp5 2/2 MECs (Figure S6).
Analysis of Lrp5 +/+ and 2/2 MECs in culture showed that a
significantly higher number of morphologically abnormal basal
cells appeared in Lrp5 2/2 MECs. The flattened, stressed
morphology is illustrated best by staining for smooth muscle actin
(SMA) (Fig. 6D). To determine whether these abnormal basal cells
in Lrp5 2/2 MECs were senescent, we examined the expression
of p16
Ink4a in cultured primary MECS. mRNA levels of p16
Ink4a
were significantly up-regulated (3.5x) in Lrp5 2/2 MECs (Fig. 6E).
To find out whether this reflected specific changes in the basal
lineage, cells were purified from these populations, and the luminal
and basal cells cultured independently. p16
Ink4a expression was
significantly increased in both the basal and luminal cells of Lrp5
2/2 mammary glands (Fig. 6F).
Another basal marker that showed significantly attenuated
expression in these glands is p63 (a p53 family member). Expression
of this gene is under the control of two distinct promoters, and the
properties of each product are functionally associated with different
stages of differentiation. Thus, a full length TA-p63 isoform may
regulate p53-dependent transcription and has been associated with
senescent cells [36,37]. In contrast, expression of the truncated DN-
p63 isoform, which suppresses p53 function, is associated with
proliferative cell compartments [37,38]. mRNA isolated from
MECs from Lrp5 +/+, 2/2,a n dMMTV-Wnt1 mice showed
higher levels of levels of DN-p63 in MMTV-Wnt1 MECs, and very
low TA-p63. Lrp52/2 MECS showed a reciprocal pattern, with
relatively higher TA-p63 (Fig. 6G).
Loss of Lrp5 does not Affect the Wnt Signaling
Transactivation Response of Cultured Mammary
Epithelial Cells
Using qPCR, we evaluated the relative expression of Lrp5 and
Lrp6 in Lrp52/2 mice, to determine whether there was a
compensatory expression pattern for Lrp6 in the absence of Lrp5.
The amount of Lrp6 mRNA was unchanged in Lrp52/2 MECs
Figure 3. Lrp6 is co-expressed by Basal Mammary Epithelial Cells. A) BALB/c virgin MECs were stained with CD24, CD49f, and Lrp6 prior to
FACS analysis. MECs were divided into Lrp6+/high and Lrp6-/low, and these populations were overlaid onto the CD24/CD49f profile (Lrp6+ in blue,
Lrp6- in red). B) Basal MECs were analyzed as described in Fig. 2b, to test the magnitude of Lrp6 expression relative to CD24/CD49f. C) Lrp6+, Lrp6-,
and whole population (WP) MEC fractions were isolated by FACS and subsequently stained for K5 and K8 to determine their cellular phenotype.
doi:10.1371/journal.pone.0006594.g003
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PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6594Figure 4. Lrp5 is Expressed by Cells that Co-Purify with Stem Cells by Flow Cytometry. A) Single cell preparations of virgin BALB/c MECs
were stained with CD24, CD49f, CD45, and CD31, in addition to Lrp5 prior to FACS analysis. Gates were set to distinguish Lrp5 negative (red), low
(blue), and high (green) expressing MECs. The CD24/CD49f profiles for each population were then overlaid. Arrow in Lrp5 high panel indicates
previously uncharacterized region of CD24/CD49f profile. B) MECs were stained with von Willebrand factor (VWB), in addition to CD49f and CD24.
Gates were drawn to indicate VWB positive and negative populations and the CD24/CD49f profiles were plotted for each respective population.
Arrow indicates VWB+ cell population that co-localizes with a fraction of Lrp5 high MECs shown in A. C) Lrp5+ and Lrp5- MEC fractions were isolated
by FACS and stained for Vimentin and VWB expression.
doi:10.1371/journal.pone.0006594.g004
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transactivation, we used endogenous Wnt target gene expression
(to circumvent artifacts associated with transfection of highly
refractive primary cells). Axin2 and Gpr49 are downstream target
genes in the Wnt signaling pathway. In MECs from virgin mice,
the amount of Axin-2 mRNA was not affected by the absence of
Lrp5 (Fig. 7B). Cultured MECs were treated with Wnt3a-
containing conditioned medium (or control), and Axin2 was found
to be induced 66even in Lrp52/2 MECs. Similarly, a 2–
36induction of Gpr49 was observed in Lrp52/2 MECS (Fig. 7C).
Figure 5. Lrp5-High Cells are Enriched for Stem Cell Activity. A) Mammary epithelial cells were isolated from 10-week, virgin BALB/c mice,
stained for Lrp5 and FACS sorted, as described above. Lrp5 high (red) and negative (green) MECs were then transplanted into cleared fat pads of 3-
week BALB/c recipient mice. Following 8 weeks, mammary glands were harvested, carmine stained, and scored for primary outgrowths, as described
above. Transplantations of the MRU sub-population (black), in addition to the FACS sorted, unfractionated population (Whole Population, gray)
served as controls. Left panel is a representative CD24/CD49f FACS profile, depicting overlaid Lrp5- (red), Lrp5 low (blue), and Lrp5 high (green)
populations. B) Estimation of stem cell frequencies for each transplanted population. Stem cell frequencies, fold enrichment, and p values were
calculated using limdil software (http://bioinf.wehi.edu.au/software/limdil).
doi:10.1371/journal.pone.0006594.g005
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PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6594Figure 6. In Lrp5 Null Glands, the Basal Cell Population is Depleted. A) FACS analysis of Lrp5 +/+, 2/2, and MMTV-Wnt1 MECs stained with
CD49f and CD24. Gates were drawn to indicate the luminal and basal lineages. Right panel, quantification of the ratio of basal to luminal cells from
three independent FACS analyses of CD24/CD49f profiles, shown in left panel. B) Western analysis of lysates prepared from uncultured Lrp5 +/+, 2/2,
and MMTV-Wnt1 MECs. Blots were probed with the basal cell marker, K5, and re-probed with tubulin, as a loading control. C) Representative heatmap
and statistical analysis of basal markers from microarray of Lrp5 +/+ and 2/2 MECs. Samples were analyzed by GeneSifter software and compared by
t-test, *p,0.05. D) Immunofluorescent staining of cultured Lrp5 +/+ and 2/2 MECs. Cells were cultured for 3 days in normal culture media and
stained for K8 (red), SMA (green), and DNA (blue), scale bars=20 mm. Insets depict 56enlargements, scale bars=4 mm. The number of large, flattened
SMA positive cells were quantified from several fields of immunofluorescent staining of Lrp5 +/+ and 2/2 cultured MECs from two independent
experiments. E) Quantification of p16
Ink4a mRNA levels from Lrp5 +/+ and 2/2 MECs, after 3 days of culture. F) Quantification of p16
Ink4a mRNA
expression levels of purified luminal and basal Lrp5 +/+ and 2/2 MECs after culture. mRNA levels were normalized to the housekeeping genes, TBP
and HPRT. Normalized expression=2
2DCt (see Methods S1). G) Quantification of TA-p63 and DN-p63 mRNA expression levels of uncultured Lrp5+/+,
2/2, and MMTV-Wnt1 MECs. Data is expressed as fold change over Lrp5 +/+. Data were compared by Wilcoxon Rank Sum Test. Significance was
established at p,0.05.
doi:10.1371/journal.pone.0006594.g006
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MECs was not due to the up-regulation of Lrp6 in response to
culture conditions, since Lrp6 mRNA levels remained relatively
unchanged throughout the culture period (Figure S7). Taken
together, these results indicate that although there was a significant
change in the physiology of Lrp52/2 glands, the canonical Wnt
response was largely normal. Potential explanations for that are
described in the Discussion section.
Discussion
Previously, we have shown that Wnt1-induced, hyperplastic
mammary glands accumulate undifferentiated cells (of both basal
and luminal lineages) and ductal regenerative/stem cells (as a
proportion of total) [9]. Here, we show an increased proportion of
basal cells (measured by their CD24/CD49f profile and higher
relative expression of basal marker proteins/total protein) and
increased expression of a basal cell-associated p63 variant, DNp63,
associated with proliferative function in basal cell lineages. These
glands subsequently develop solitary differentiated tumors with
multiple lineage characteristics. We show here (and Lindvall et al,
2006) that loss of Lrp5 generates the reciprocal phenotype – slower
ductal outgrowth, the accumulation of peri-senescent cells (of both
lineages), almost total depletion of adult regenerative cells from the
ductal tree, a reduced proportion of basal cells compared to
luminal, and increased expression of the TAp63 isoform, associated
with senescence. We predict that these glands will be highly tumor
resistant (for tumors arising in a basal cell precursor).
We have shown that Lrp5 is expressed together with Lrp6 on
most/all basal cells of the mammary gland. However, most basal
cells have a low cell surface expression of Lrp5, and only cells with
a high level have enriched stem cell function. This fraction
includes 80% of the mammary stem cells. Lrp5 is unique amongst
the markers described so far for mammary epithelial populations
for providing significant levels of stem cell enrichment without
combining it with other markers.
Wnt1-induced mouse mammary tumors share a transcriptional
signature with Brca1+/2 and carcinogen-induced tumors [39],
and these in turn share components of their basaloid signature
with human basaloid tumors [40]. Characteristically, all of these
tumors have residual basal cells, and are likely to derive from the
basal lineage. It is perhaps not surprising then that the key
components of the oncogenic Wnt signaling pathway are
specifically expressed by basal cells.
There are data to suggest that gain of function of Lrp5 or -6 is
important to breast cancer. Some human breast cancer cells have
Figure 7. Wnt Signaling of Whole Populations is not Significantly Affected by the Absence of Lrp5. A) Quantification of Lrp5 and Lrp6
mRNA levels in Lrp5 +/+ and 2/2 MECs. B) Quantification of expression of the Wnt target gene, Axin2, mRNA in Lrp5 +/+ and 2/2 MECs. C)
Quantification of Axin2 and Gpr49 mRNA expression levels in Lrp5 +/+ and 2/2 MECs treated with Wnt3a or control conditioned media. All samples
were cultured for three days and mRNA levels were normalized to the expression of the housekeeping genes, TBP and HPRT (as described in the
Methods section). Normalized expression=2
2DCt (see Methods S1). Data shown in A were compared by unpaired Student’s t-test. Data shown in B
and C were compared by Wilcoxon Rank Sum Test. Significance was established at p,0.05.
doi:10.1371/journal.pone.0006594.g007
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splice variant of Lrp5, DLrp5, was found in the majority (85%) of
breast tumors, and was required for their continued growth. The
deletion of the variant exons by splicing was associated with
resistance to inhibition by Dkk1 [41]. These data suggest that
ectopic Wnt signaling could be an important source of growth
dysregulation in breast tumors. These tumors are not all basaloid,
they include tumors of many classes, which suggests that the Lrp5-
dependent growth pathway could become viable in many
candidate tumor precursor cell types.
Lrp5 and -6 are co-expressed in the majority of basal cells. Lrp6
co-expression is high enough that the absence of Lrp5 has no effect
on Wnt transactivation in response to Wnt3A (with no gross
transcriptional compensation of Lrp6 mRNA). However, there is a
very specific effect of the loss of Lrp5 on the maintenance of adult
somatic stem cell activity. This corresponds to the lack of
tumorigenicity of Wnt1 in Lrp52/2 mammary glands (Lindvall
et al, 2006). This could be explained by the following scenarios - 1)
Lrp5 has a distinct function in mammary stem cell biology
compared to Lrp6, 2) Lrp5 expression augments Lrp6 expression
to push the total expression over a critical threshold for growth
promotion, 3) both Lrp5 and -6 are required for the stem cell
function, 4) the ligand for Lrp5/Fzd is not Wnt1/Wnt3A (whereas
Wnt3A binds and stimulates Lrp6/Fzd), or 4) Lrp5 has a different
subcellular presentation from Lrp6.
Often, Lrp5/6 are used in experiments interchangeably, since
they exhibit high sequence homology. Though they show similar
expression patterns in embryonic and adult tissues [42,43,44], they
have distinct functions. For example, an allelic series of mutations
in Lrp5 and 6 in mouse embryos revealed that the Lrp5 loss in
combination with Lrp6 loss produces a more severe phenotype
than Lrp6 loss alone, and that Lrp6 loss is more severe than Lrp5
loss alone [22,45]. The loss of Lrp5 tends to produce a subset of the
phenotypes typical of Lrp6 null mice. One possibility is relative
ligand specificity, and this may be influenced by the presence of
LDLR repeat sequences in the extracellular domains. Although
the extracellular domains are highly conserved between the two
receptors (73%), the LDLR repeats demonstrate significantly
lower sequence homology [44]. In addition, the extraceullar
domain of Lrp6 contains 10 putative glycosylation sites, whereas
Lrp5 only contains 5, which may also play a role in directing
ligand specificity.
Another possible mechanism leading to the divergent functions of
Lrp5 and 6 may be cell surface presentation and intracellular
processingofthereceptors.InternalizationofLrp6hasbeenfoundto
be regulated by clathrin, caveolin, ligand interaction (including R-
spondin) and c-secretase-dependent mechanisms [46,47,48,49,50],
indicating Lrp6 (and possibly Lrp5) activity can be regulated by
different internalization patterns. Although the internalization
mechanism of Lrp5 is unknown, it likely differs from that of Lrp6,
since the intracellular domains are much less conserved [44].
It is likely that Wnt ligands have specific cognate Frizzled
receptors. This specificity has been demonstrated for Wnt5A,
which can induce canonical signaling only when Fzd4 and Lrp5
(not Lrp6) are present [51]. Wnt5A is known to be expressed and
bioactive during mouse mammary gland development; a gain of
function inhibits ductal outgrowth, and loss promotes hyperpro-
liferation [52]. Most Fzd mRNAs are expressed in virgin ductal
mammary glands, except for Fzd4. If Fzd4 is expressed, it is a very
low level, or in a very small subpopulation (unpublished data, Y C
Kim and C M Alexander).
The overall output of canonical and other responses depends
upon the relative amount of receptors and ligands. Non-canonical
and canonical pathways can inhibit each other, and even non-
productive interactions (for example Wnt5A:Lrp6) can compete
with normal signaling activities (for example, activation of the non-
canonical target Rac1) [53,54]. It is possible that Lrp5 binds
Wnt5A during normal development (with no canonical signaling
effect), but the absence of Lrp5 enhances the inhibitory effects of
Wnt5A on ductal outgrowth (and more specifically, stem cell self-
renewal).
Although the embryonic outgrowth of mammary rudiments is
Wnt-dependent [15,16], the phenotype of early mammary
development of Lrp52/2 mice is only marginally affected. This
suggests that only the adult somatic ductal stem cells require Lrp5,
for either 1) stem cell specification during tree outgrowth, or 2)
survival in adult glands. Prior modeling has predicted that if most
cells in the mammary rudiment have at least 30 division cycles,
there is a reserve of growth potential [55]. In fact, the challenge of
development appears to be to control and attenuate the growth
potential to enable functional differentiation. In other words, there
is no need to invoke stem cells to explain the growth associated
with ductal outgrowth, estrus cycling, or pregnancy. The Lrp5 null
mouse is an example of this, as is the b1 integrin null mouse
[56,57,58]. Both these strains show approximately normal ductal
extension, but neither ductal tree has significant regenerative
capacity. Yet, we report that the stem cell-deficient gland is
affected in a predictable way. When mammary epithelial cell
populations are transferred to culture, there is increased expression
of senescence-associated markers, such as p16
Ink4a and TAp63.
(Our data suggests that senescence markers are transient in vivo,
unless glands are actively growing; presumably cells are removed
by apoptosis or autophagy). By separating the luminal and basal
cells for independent culture, we show that the effect of the Lrp5
null mutation is evident not only in the basal cell population
(where we would anticipate the effect of this mutation), but also in
the luminal cells. We propose that this is consistent with the stem
cell origin of this effect.
Cellular senescence is described as a natural mechanism of
tumor suppression [59]. The mechanism of several tumor
suppressors has been demonstrated to be the induction of
senescence or apoptosis. More specifically, it has been proposed
that tumor suppressors may act by reducing the stem/progenitor
cell pool, since overexpression often leads to a reduction in the
regenerative capacity of a tissue [59]. For example, the tumor
suppressor, p16
Ink4a, is thought to act this way. It is deleted or
inactivated in numerous tumors, whereas overexpression results in
senescence and an aged phenotype [60]. Indeed, ectopic p16
Ink4a
expression has been shown to deplete stem cell activity in a
number of tissues (brain, pancreas, and hematopoetic system)
[61,62].
Similar to p16
Ink4a, p53, is also a widely recognized tumor
suppressor, where loss of function mutations are associated with
tumorigenesis and gain of function mutations result in aging and
senescence [59]. p63 is a closely related family member to p53, yet
very little is known about the function of this protein. It has been
shown to be required for mammary gland development [63] and is
frequently up-regulated (although, not mutated) in several
epithelial cancers [38]. The TAp63 isoform has been shown to
be pro-apoptotic [64] and can bind to p53 response elements,
driving transcription of p53 target genes. The DNp63 isoform,
however, acts as a dominant-negative competitor for TAp63 and
p53 [65]. The DNp63 isoform is expressed at higher levels than
TAp63 during development and at lower levels during differen-
tiation [66,67]. Consequently, it has been suggested that the ratio
of DNp63 to TAp63 isoform expression may dictate whether a cell
follows its normal differentiation program, becomes senescent, or
undergoes oncogenic transformation [38]. It is, therefore, not
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human breast cancers [38]. Interestingly, DNp63 has been shown
to interact with and regulate the Wnt signaling pathway,
promoting cell proliferation [68]. Thus, Wnt signaling through
Lrp5 may regulate the proliferative potential of the basal
mammary stem cell population by inhibiting senescence (as it
does in various human cell lines in vitro, [69]). We conclude that
profound differences in regenerative potential are not necessarily
reflected at the gross level of epithelial organogenesis. Instead,
there are changes in the predisposition of the cellular populations
to senescence, and perhaps to growth stimuli and transforming
events.
Materials and Methods
Mice and Materials
C57Bl6 Lrp5 +/+, 2/2 [29,70], C57Bl6 MMTV-Wnt1 [71],
C57BL/6-Tg(CAG-EGFP)1Osb/J (strain 003291, ubiquitous EGFP
expression, driven by b-actin promoter) and BALB/c (Jackson
Labs, Bar Harbor, ME) mice were bred and maintained in
accordance with the guidelines set forth by the National Institutes
of Health Guide for the Care and Use of Laboratory Animals,
published by the U.S. Public Health Service. All experimental
protocols were approved by the Institutional Animal Care and Use
Committee at the University of Wisconsin-Madison. Fluorescent
conjugated rat monoclonal antibodies against CD49f (GoH3),
CD24 (M1/69), CD45 (30-F11), and CD31 (MEC 13.3) were
purchased from BD Biosciences (San Jose, CA). Mouse anti-Lrp6
was generated as previously described [46] and Lrp5 (41–130) was
purchased from Abnova (Taipei City, Taiwan). Mouse monoclo-
nal antibodies against SMA (1A4), tubulin (JDR.3B8), and actin
(AC-15) were purchased from Sigma Aldrich (St. Louis, MO).
Rabbit anti-K5 was purchased from Covance (Madison, WI),
rabbit-anti VWB was purchased from Dako (Glostrup, Denmark),
and rat anti-K8 (Troma-I) was purchased from the Developmental
Studies Hybridoma Bank (University of Iowa). All fluorescent
conjugated secondary antibodies were purchased from Molecular
Probes (Eugene, OR).
MEC Isolation and Culture
MECs were prepared from mouse mammary glands as
previously described [34], using reagents and protocol from Stem
Cell Technologies (Vancouver, CA). Briefly, mammary glands
were isolated from virgin or 14 day pregnant 12–14 week old
C57Bl6 Lrp5 +/+, 2/2, MMTV-Wnt1,o rBALB/c virgin mice.
The mammary glands were cut into small pieces with fine scissors
and digested for 6 hours, 37uC in Epicult-B supplemented with
5% fetal bovine serum, 300 U/mL collagenase and 100 U/mL
hyaluronidase. The resulting mammary organoids were washed,
counted, and frozen in DMEM containing 10% FBS and 10%
DMSO until further use. Prior to cell culture, mammary organoids
were reduced to single cells by digesting in consecutive one-minute
incubations with trypsin and dispase. The cells were passed
through a 70 mm mesh filter prior to seeding into Matrigel-coated
plates [72]. Cells were maintained in either normal culture media
(DMEM supplemented with 10% FBS, 10 mg/ml insulin, and
100 U/m Pennicillin/Streptomycin) or L-Cell (Con) or Wnt-3a
(Wnt) conditioned media [73] diluted 50% with normal culture
media.
Northern Blotting
Lrp5 +/+, +/2, and 2/2 embryos were isolated from
approximately 18 day pregnant mice, flash frozen in liquid
nitrogen, and transferred to RNAlater -ICE (Ambion, Foster City,
CA) before RNA isolation. A similar strategy was used for isolated
MECs and cell lines (RNAlater (Ambion)/RNeasy mini kit;
Qiagen). NMuMG cells were cultured in DMEM supplemented
with 10% FBS and 10 mg/mL insulin (Sigma). HC11 cells were
cultured in RPMI 1640 supplemented with 10% FBS, 5 mg/mL
insulin, and 10 ng/mL rEGF (R&D Systems, Minneapolis, MN).
The preparation of Northern blots and probes is described in
Methods S1.
Western Blotting
Embryos isolated from 10–12 day pregnant C57Bl6 Lrp5 +/+ or
Lrp5 2/2 mice were homogenized for 1 min/4uC in ‘‘Streuli’’
lysis buffer [74] using a Polytron homogenizer. Cultured cells were
harvested by scraping into culture medium, centrifuged at 1806g
for 5 min, resuspended in lysis buffer, and incubated for 30
minutes on ice. Fresh, purified mammary epithelial cells were
quickly thawed, washed with culture media, resuspended in lysis
buffer, and incubated for 30 min on ice. All lysates were cleared at
12,0006g for 30 min. Supernatants were removed and protein
concentration determined (using Bradford reagent (Pierce, Rock-
ford, IL)) and analyzed by SDS-PAGE and immunoblotting (as
previously described [72]).
Immuofluorescence
Mammary tissue sections were prepared from either virgin or
10–12 day pregnant, adult female Lrp5 +/+ and Lrp5 2/2 mice.
Virgin mammary glands were fixed overnight in 2% paraformal-
dehyde at 4uC, embedded in paraffin, and sectioned (8 mm).
Tissues were deparaffinized, re-hydrated, and blocked with 10%
non-immune goat serum for 1 h at room temperature. Pregnant
mammary glands were frozen in OCT compound (Electron
Microscopy Sciences, Hatfield, PA) prior to sectioning. Frozen
sections were fixed in acetone for 20 min at room temperature
prior to blocking with 10% non-immune goat serum for 1 h and
overnight incubation with anti-Lrp5, K5, SMA, or K8 antibodies.
Samples were incubated with anti-mouse IgG-Alexa 488 and anti-
rabbit or rat IgG-Alexa 546 secondary antibodies for 2 h at room
temperature. Nuclei were stained by incubation with ToPro3
(Molecular Probes) for 30 min prior to visualization using confocal
microscopy (Radiance 2100, Biorad, Hercules, CA). For ‘‘cytos-
plats,’’ single cell suspensions of FACS sorted mammary epithelial
cell populations were dried briefly onto microscope slides and fixed
in ice-cold methanol and acetone for 4 and 2 minutes, respectively.
Cell preparations were blocked in 10% non-immune goat serum
and stained as above. The number of K5 and K8 positive cells
were quantified by manual counting of at least 100 cells in three
random fields per experimental sample.
Flow Cytometry
Single cell suspensions of BALB/c mammary epithelial cells were
prepared from frozen preparations of mammary organoids, as
described above. The resulting single cell suspensions were stained
with Lrp5 or Lrp6 in addition to fluorescent conjugated rat
monoclonal antibodies to CD49f, CD24, CD45, and CD31 for
30 min on ice. The cells were washed and incubated with anti-
mouse IgG-Alexa 405 for 30 min on ice, and analyzed on a
FACSVantage cell sorter with DiVa software (Becton Dickson,
Franklin Lakes, NJ). Live cells were discriminated by propidium
iodide exclusion. CD45 and CD31 positive cells were excluded
prior to gating of populations based on Lrp5 expression levels. For
functional evaluation, cell populations which exhibited high, low,
or negative Lrp5 staining, together with a CD24
+CD49f
high
(MRU) fraction for comparison, were sorted into pure fetal bovine
serum, centrifuged at 7006g for 5 min, re-suspended in culture
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to transfer into recipient mice. To identify the population of Lrp5
high expressing cells that were not localized to the MRU sub-
population, virgin BALB/c MECs were stained with anti-VWB in
addition to CD49f and CD24.
Microarray
MECs were isolated from 6 groups of Lrp5+/+ and 3 groups of
Lrp52/2 mice, as described above. Each sample group comprised
5 mice each that spanned 12–16 weeks of age. Estrous staging was
performed on the mice by vaginal cytological examination and
mice belonging to different stages of the cycle were assigned to
each group randomly. Total RNA was isolated from MECs using
the Qiagen RNeasy kit (Qiagen), as described above. The isolated
RNA was submitted to the Gene Expression Center, University of
Wisconsin-Madison where a quality control test was performed on
the RNA samples. RNA from each group was used for cDNA
synthesis followed by labeling of the cDNA with Cy3. The labeled
cDNA samples were submitted to NimbleGen and hybridized to
Mus musculus 1-Plex arrays (Roche NimbleGen, A4543-00-01)
that represent 42,586 mouse genes. The single color NimbleGen
arrays were scanned with a GenePix 4000B microarray scanner.
The data was extracted from scanned images using NimbleScan
software and the Robust Multichip Average (RMA) algorithm
used to generate gene expression values. The details of labeling,
hybridization, scanning and normalization of the data are
described in detail on the NimbleGen website (http://www.
nimblegen.com). The normalized data was subsequently analyzed
using GeneSifter, an online microarray data analysis system
(http://www.genesifter.net). Heat maps were generated from
pooled Lrp5 +/+ and 2/2 samples. T-tests were used to
determine the statistical significance between the two groups
which was established at p,0.05.
Quantitative RT-PCR
Lrp5 +/+ and 2/2 MECs from 12–14 week old mice were
cultured on matrigel-coated plates and treated with Wnt-3a (Wnt)
or L Cell (Con) conditioned media for 16 h, 1, 2, or 3 days. Total
RNA was isolated using the RNeasy Mini Kit (Qiagen) according
to manufacturer instructions. cDNA was generated using a mix of
oligo dT and random primers using QuantiTect Reverse
Transcription Kit (Qiagen). cDNA (100 ng) was amplified by real
time PCR using 5 mL SYBR Green qPCR SuperMix-UDG with
Rox (Invitrogen) and 4 mL of forward and reverse primers
(0.5 mM). The analysis was performed on each sample in triplicate
with an ABI 7900-HT (Applied Biosystems, Foster City, CA).
Relative transcript levels were calculated using the comparative Ct
method and normalized to the previously characterized house-
keeping genes, tata binding protein (TBP) and hypoxanthine-
guanine phosphoribosyltransferase (HPRT) [75]. Primer sequences
and additional methods are described in Methods S1.
Mammary Reconstitution Assay
Mammary glands of 3-week old BALB/c virgin mice were
cleared of endogenous epithelium as previously described [76].
Populations of mammary epithelial cells isolated by flow cytometry
were quickly thawed, washed, counted, and re-suspended in
DMEM containing 5 mg/mL Matrigel and loading dye (5%
glycerol/0.5% trypan blue/25 mM HEPES pH 7.2). A 1 mL
volume of cell suspension containing 50–50,000 cells was injected
into each cleared fat pad of the recipient mice. The fat pads were
removed 8 weeks following transplants, fixed in 2% PFA overnight
at 4uC, stained with carmine alum, dehydrated in ethanol, and de-
fatted in xylene. Outgrowths were subsequently identified using a
light microscope, photographed, and the number of outgrowths
quantified for each dose of cells transplanted.
Estimation of Stem Cell Frequencies and Statistical
Analyses
Stem cell frequencies were estimated using the limdil software
for limiting dilution analysis (http://bioinf.wehi.edu.au/software/
limdil). All other data were compared by either unpaired Student’s
T-test or Wilcoxon Sum Rank test, using Mstat 4.0 statistical
software (Norman Drinkwater, McArdle Laboratory). Significance
was established at p,0.05.
Supporting Information
Figure S1 Evaluation of Antibody Specificity. To determine
whether there is any cross-reactivity between the Lrp5 and Lrp6
antibodies, 293 cells were transfected with plasmids encoding Lrp5
or Lrp6. A) Western blot of transfected 293 cell lysates for Lrp5
and Lrp6. Actin was used as a loading control. B) Immunofluo-
rescence of transfected 293 cells stained for either Lrp5 or Lrp6
(red). Nuclei were stained with ToPro3 (blue). C) FACS analysis of
transfected 293 cells. Gates were set based on staining levels seen
in the untransfected control samples. Scale bar=50 mm.
Found at: doi:10.1371/journal.pone.0006594.s001 (3.84 MB TIF)
Figure S2 Specificity of Lrp5 Antibody Staining of MECs by
FACS. A) C57Bl6 Lrp5 +/+ MECs were isolated, reduced to
single cell suspensions, and stained with anti-Lrp5, in addition to
CD24 and CD49f (and Lin antisera) prior to FACS analysis. B)
C57Bl6 Lrp5 2/2 MECs were isolated and stained as described
in A. Top Panels: gating strategy for exclusion of cell doublets,
apoptotic (PI+), hematopoetic (CD45+), and endothelial (CD31+)
cells. Bottom Panels: Gates were drawn for Lrp5 expression on the
basis of the staining pattern for the Lrp52/2 MEC population.
Lrp5 positive (blue) and Lrp5 negative (red) populations were
overlaid on the CD24/CD49f staining profile.
Found at: doi:10.1371/journal.pone.0006594.s002 (3.01 MB TIF)
Figure S3 Ductal Outgrowth of Lrp5 2/2 MECs is Enhanced
by the Presence of GFP Labeled Control Cells. MECs were
isolated from C56Bl6 Lrp5 2/2 and Actin-GFP mice (12–14
weeks old). They were counted and mixed in various proportions
to total 10,000 cells, and then tested for their relative
reconstitution activity after transfer into cleared fat pads of
C57Bl6 Lrp5 +/+ mice. Outgrowths were analyzed for the
presence of GFP positive cells, and subsequently Carmine stained.
They are presented as % colonization of glands, and % of each
outgrowth that is GFP+ (black=proportion of unlabeled cells;
green=proportion of GFP+ cells).
Found at: doi:10.1371/journal.pone.0006594.s003 (1.33 MB TIF)
Figure S4 The Ductal Stem Cell Deficiency Observed in
Lrp52/2 Glands does Not Affect Ductal Integrity after Multiple
Rounds of Parity. Control (A) and Lrp52/2 (B) glands were
evaluated by whole mount staining, and show similar structure
and fat pad colonization. Scale bar=1 mm.
Found at: doi:10.1371/journal.pone.0006594.s004 (3.89 MB TIF)
Figure S5 K5 mRNA Expression is Decreased in Lrp5 2/2
MECs and Embryos. A) Quantification of K5 mRNA expression in
uncultured Lrp5 +/+, 2/2, and MMTV-Wnt1 MECs. B)
Quantification of K8 mRNA expression in Lrp5 +/+, 2/2,a n d
MMTV-Wnt1 MECs. C) Quantification of K5 mRNA expression in
E10-12 Lrp5 +/+, +/2,a n d2/2 embryos. D) Quantification of K8
mRNAexpressionin E10-12 Lrp5 +/+,+/2,a nd2/2embryos.All
data were normalized to the housekeeping genes TBP and HPRT.
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Figure S6 Lrp5 2/2 MECs are Depleted in Markers Expressed
by MRUs. Representative heatmap and stastical analysis micro-
array of Lrp5 +/+ and 2/2 RNA samples. Genes previously
characterized to be up-regulated in MRUs (Stingl et al, 2006) were
compared for each sample using GeneSifter software. Data were
compared by student’s t-test, *p,0.05.
Found at: doi:10.1371/journal.pone.0006594.s006 (0.96 MB TIF)
Figure S7 Cell Culture Does not Alter Lrp5/6 Expression. A)
RNA from cultured Lrp5 +/+ and 2/2 MECs was isolated from
cells daily, and quantitative RT-PCR was performed for Lrp5 (A)
and Lrp6 (B). Expression levels were normalized for each sample
using the housekeeping genes, TBP and HPRT.
Found at: doi:10.1371/journal.pone.0006594.s007 (0.40 MB TIF)
Methods S1
Found at: doi:10.1371/journal.pone.0006594.s008 (0.03 MB
DOC)
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